[1]孙钰椋,刘彦礼,林俊堂.经血源子宫内膜干细胞在新型冠状病毒肺炎治疗中的应用前景[J].新乡医学院学报,2020,37(3):201-205.[doi:10.7683/xxyxyxb.2020.03.001]
点击复制

经血源子宫内膜干细胞在新型冠状病毒肺炎治疗中的应用前景
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
37
期数:
2020年3
页码:
201-205
栏目:
专题报告
出版日期:
2020-03-12

文章信息/Info

作者:
孙钰椋刘彦礼林俊堂
(新乡医学院干细胞与生物治疗技术研究中心,河南 新乡 453003)
关键词:
新型冠状病毒新型冠状病毒肺炎间充质干细胞经血源子宫内膜干细胞
分类号:
R563.1
DOI:
10.7683/xxyxyxb.2020.03.001
文献标志码:
A
摘要:
2019年12月以来,我国出现了由新型冠状病毒(SARS-CoV-2)感染引起的肺炎患者,目前,突发疫情虽然在我国得到了有效控制,但在世界范围内疫情加剧。新型冠状病毒肺炎(COVID-19)目前尚无直接有效的治疗措施。近年来,以干细胞为基础的细胞疗法在临床上取得了突破性进展。研究发现,干细胞能够通过旁分泌作用和免疫调节作用显著改善急性肺损伤,为干细胞治疗COVID-19带来希望。经血源子宫内膜干细胞(MenSCs)相比于其他类型的干细胞具有更广泛的来源及应用前景,本文对MenSCs相关研究进展进行综述,并深入分析其用于治疗COVID-19的可行性,为临床治疗COVID-19重症患者提供新的思路。

参考文献/References:

[1] 张彦平.中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组.新型冠状病毒肺炎流行病学特征分析[J].中华流行病学杂志,2020,41(2):145-151
[2] SONG F,SHI N,SHAN F,et al.Emerging coronavirus 2019-nCoV pneumonia[J].Radiology,2020:200274.DOI:10.1148/radiol.2020200274.
[3] CINESI GO MEZ C, PENUELAS RODRI GUEZ O , LUJA N TORNE M,et al.Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection[J].Med Intensiva,2020,pii:S0210-5691(20)30094-2.DOI:10.1016/j.medin.2020.03.005.
[4] HUI D S,I AZHAR E,MADANI T A,et al.The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health:the latest 2019 novel coronavirus outbreak in Wuhan,China[J].Int J Infect Dis,2020,91:264-266.
[5] BELLANI G,LAFFEY J G,PHAM T,et al.Epidemiology,patterns of care,and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries[J].JAMA,2016,315(8):788-800.
[6] ALBERT R K,SMITH B,PERLMAN C E,et al.Is progression of pulmonary fibrosis due to ventilation-induced lung injury[J].Am J Respir Crit Care Med,2019,200(2):140-151.
[7] SCHMIDT M,FRANCHINEAU G,COMBES A.Recent advances in venovenous extracorporeal membrane oxygenation for severe acute respiratory distress syndrome[J].Curr Opin Crit Care,2019,25(1):71-76.
[8] COMBES A,PESENTI A,RANIERI V M.Fifty years of research in ARDS.Is extracorporeal circulation the future of acute respiratory distress syndrome management[J].Am J Respir Crit Care Med,2017,195(9):1161-1170.
[9] HAN J,LI Y,LI Y.Strategies to enhance mesenchymal stem cell-based therapies for acute respiratory distress syndrome[J].Stem Cells Int,2019,2019:5432134.
[10] TSUJI K,KITAMURA S,WADA J,et al.Immunomodulatory and regenerative effects of mesenchymal stem cell-derived extracellular vesicles in renal diseases[J].Int J Mol Sci,2020,21(3):E756.
[11] BALAN A,LUCCHINI G,SCHMIDT S,et al.Mesenchymal stromal cells in the antimicrobial host response of hematopoietic stem cell recipients with graft-versus-host disease:friends or foes [J].Leukemia,2014,28(10):1941-1948.
[12] ANTEBI B,BEN A,BATCHINSKY A I,et al.The promise of mesenchymal stem cell therapy for acute respiratory distress syndrome[J].J Trauma,2018,84(1):183-191.
[13] WILSON J G,LIU K D,ZHUO H,et al.Mesenchymal stem (stromal) cells for treatment of ARDS:a phase 1 clinical trial[J].Lancet Respir Med,2015,3(1):24-32.
[14] LENG Z,ZHU R,HOU W,et al.Transplantation of ACE2- mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia[EB/OL].(2020-02-28)[2020-03-01].http://www.chinaxiv.org/abs/202002.00080.
[15] PUSA T,BARANOWSKA A,BARANOWSKI P.Stem cells in contemporary medicine[J].Pol Merkur Lekarski,2019,46(271):5-8.
[16] CHEN J Y,MOU X Z,DU X C,et al.Comparative analysis of biological characteristics of adult mesenchymal stem cells with different tissue origins[J].Stem Cell Res Ther,2015,8(9):739-746.
[17] MENG X,ICHIM T E,ZHONG J,et al.Endometrial regenerative cells:a novel stem cell population[J].J Transl Med,2007,5(1):57.
[18] XU Y,ZHU H,ZHAO D,et al.Endometrial stem cells:clinical application and pathological roles[J].Int J Clin Exp Med,2015,8(12):22039-22044.
[19] YOO K H,JANG I K,LEE M W,et al.Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues[J].Cell Immunol,2009,259(2):150-156.
[20] ROMANOV Y A,DAREVSKAYA A N,MERZLIKINA N V,et al.Mesenchymal stem cells from human bone marrow and adipose tissue:isolation,characterization,and differentiation potentialities[J].Bull Exp Biol Med,2005,140(1):138-143.
[21] GANG E J,BOSNAKOVSKI D,FIGUEIREDO C A,et al.SSEA-4 identifies mesenchymal stem cells from bone marrow[J].Blood,2007,109(4):1743-1751.
[22] GRECO S J,LIU K,RAMESHWAR P.Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells[J].Stem Cells,2007,25(12):3143-3154.
[23] YAO S,CHEN S,CLARK J,et al.Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions[J].Proc Natl Acad Sci USA,2006,103(18):6907-6912.
[24] COGLE C R,YACHNIS A T,LAYWELL E D,et al.Bone marrow transdifferentiation in brain after transplantation:a retrospective study[J].Lancet,2004,363(9419):1432-1437.
[25] DE COPPI P,BARTSCH G,SIDDIQUI M M,et al.Isolation of amniotic stem cell lines with potential for therapy[J].Nat Biotechnol,2007,25(1):100-106.
[26] TOMA C,PITTENGER M F,CAHILL K S,et al.Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart[J].Circulation,2002,105(1):93-98.
[27] FATHI-KAZEROONI M,TAVOOSIDANA G.Menstrual blood stem cell transplantation in mice model of acute liver failure:does gender of recipient affect the outcome[J].Avicenna J Med Biotechnol,2019,11(4):308.
[28] ZURITA M,VAQUERO J.Functional recovery in chronic paraplegia after bone marrow stromal cells transplantation[J].Neuroreport,2004,15(7):1105-1108.
[29] MURPHY M P,WANG H,PATEL A N,et al.Allogeneic endometrial regenerative cells:an “off the shelf solution” for critical limb ischemia[J].J Transl Med,2008,6(1):45.
[30] BORLONGAN C V,KANEKO Y,MAKI M,et al.Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke[J].Stem Cells Dev,2010,19(4):439-452.
[31] WU X,LUO Y,CHEN J,et al.Transplantation of human menstrual blood progenitor cells improves hyperglycemia by promoting endogenous progenitor differentiation in type 1 diabetic mice[J].Stem Cells Dev,2014,23(11):1245-1257.
[32] JIANG Z,HU X,YU H,et al.Human endometrial stem cells confer enhanced myocardial salvage and regeneration by paracrine mechanisms[J].J Cell Mol Med,2013,17(10):1247-1260.
[33] LV Y,XU X,ZHANG B,et al.Endometrial regenerative cells as a novel cell therapy attenuate experimental colitis in mice[J].J Transl Med,2014,12(1):344.
[34] BOCKERIA L,BOGIN V,BOCKERIA O,et al.Endometrial regenerative cells for treatment of heart failure:a new stem cell enters the clinic[J].J Transl Med,2013,11(1):56.
[35] ZHONG Z,PATEL A N,ICHIM T E,et al.Feasibility investigation of allogeneic endometrial regenerative cells[J].J Transl Med,2009,7(1):15.
[36] FAYYAD-KAZAN H,FAOUR W H,BADRAN B,et al.The immunomodulatory properties of human bone marrow-derived mesenchymal stromal cells are defined according to multiple immunobiological criteria[J].Inflamm Res,2016,65(6):501-510.
[37] UCCELLI A,DE ROSBO N K.The immunomodulatory function of mesenchymal stem cells:mode of action and pathways[J].Ann N Y Acad Sci,2015,1351(1):114-126.
[38] DOKIC J M,TOMI C S Z,COLIC M J.Cross-talk between mesenchymal stem/stromal cells and dendritic cells[J].Curr Stem Cell Res Ther,2016,11(1):51-65.
[39] CHATERJEE D,MARQUARDT N,TUFA D M,et al.Human umbilical cord-derived mesenchymal stem cells utilise activin-A to suppress interferon-gamma production by natural killer cells[J].Front Immunol,2014,5:662.
[40] SHOKRI M R,BOZORGMEHR M,GHANAVATINEJAD A,et al.Human menstrual blood-derived stromal/stem cells modulate functional features of natural killer cells[J].Sci Rep,2019,9(1):1-13.
[41] PETERANDERL C,MORALES-NEBREDA L,SELVAKUMAR B,et al.Macrophage-epithelial paracrine crosstalk inhibits lung edema clearance during influenza infection[J].J Clin Invest,2016,126(4):1566-1580.
[42] BOZORGMEHR M,MOAZZENI S M,SALEHNIA M,et al.Menstrual blood-derived stromal stem cells inhibit optimal generation and maturation of human monocyte-derived dendritic cells[J].Immunol Lett,2014,162(2):239-246.
[43] KHOURY M,ALCAYAGA-MIRANDA F,ILLANES S E,et al.The promising potential of menstrual stem cells for antenatal diagnosis and cell therapy[J].Front Immunol,2014,5:205.
[44] ALCAYAGA-MIRANDA F,CUENCA J,LUZ-CRAWFORD P,et al.Characterization of menstrual stem cells:angiogenic effect,migration and hematopoietic stem cell support in comparison with bone marrow mesenchymal stem cells[J].Stem Cell Res Ther,2015,6(1):32.
[45] CUENCA J,LE-GATT A,CASTILLO V,et al.The reparative abilities of menstrual stem cells modulate the wound matrix signals and improve cutaneous regeneration[J].Front Physiol,2018,9:464.
[46] LUZ-CRAWFORD P,TORRES M J,NOL D,et al.The immunosuppressive signature of menstrual blood mesenchymal stem cells entails opposite effects on experimental arthritis and graft versus host diseases[J].Stem Cells,2016,34(2):456-469.
[47] LIU Y,NIU R,YANG F,et al.Biological characteristics of human menstrual blood-derived endometrial stem cells[J].J Cell Mol Med,2018,22(3):1627-1639.
[48] XIANG B,CHEN L,WANG X,et al.Transplantation of menstrual blood-derived mesenchymal stem cells promotes the repair of LPS-induced acute lung injury[J].Int J Mol Sci,2017,18(4):E689.
[49] FATHI-KAZEROONI M,TAVOOSIDANA G,TAGHIZADEH-JAHED M,et al.Comparative restoration of acute liver failure by menstrual blood stem cells compared with bone marrow stem cells in mice model[J].Cytotherapy,2017,19(12):1474-1490.
[50] ALEAHMAD M,GHANAVATINEJAD A,BOZORGMEHR M,et al.Menstrual blood-derived stromal stem cells augment CD4+ T cells proliferation[J].Avicenna J Med Biotechnol,2018,10(3):183-191.
[51] CHEN L,QU J,XIANG C.The multi-functional roles of menstrual blood-derived stem cells in regenerative medicine[J].Stem Cell Res Ther,2019,10(1):1-10.
[52] XIANG B,CHEN L,WANG X,et al.Transplantation of menstrual blood-derived mesenchymal stem cells promotes the repair of LPS-induced acute lung injury[J].Int J Mol Sci,2017,18(4):689.
[53] WANG X J,XIANG B Y,DING Y H,et al.Human menstrual blood-derived mesenchymal stem cells as a cellular vehicle for malignant glioma gene therapy[J].Oncotarget,2017,8(35):58309.
[54] CHEN L,QU J,CHENG T,et al.Menstrual blood-derived stem cells:toward therapeutic mechanisms,novel strategies,and future perspectives in the treatment of diseases[J].Stem Cell Res Ther,2019,10(1):406.
[55] PETERANDERL C,MORALES-NEBREDA L,SELVAKUMAR B,et al.Macrophage-epithelial paracrine crosstalk inhibits lung edema clearance during influenza infection[J].J Clin Invest,2016,126(4):1566-1580.
[56] HORIE S,MASTERSON C,DEVANEY J,et al.Stem cell therapy for acute respiratory distress syndrome:a promising future[J].Curr Opin Crit Care,2016,22(1):14-20.
[57] TAN J,LI P,WANG Q,et al.Autologous menstrual blood-derived stromal cells transplantation for severe Asherman′s syndrome[J].Hum Reprod,2016,31(12):2723-2729.

相似文献/References:

[1]王寅彪,宋 杰,吴卫东.新型冠状病毒感染初步认识[J].新乡医学院学报,2020,37(3):206.[doi:10.7683/xxyxyxb.2020.03.002]

更新日期/Last Update: 2020-03-05